Ghost Tree Capital, LLC Buys Kura Oncology Inc, iShares Russell 2000 ETF, Celldex Therapeutics Inc, Sells Travere Therapeutics Inc, Constellation Pharmaceuticals Inc, Rocket Pharmaceuticals Inc

• New Purchases: IWM, CLDX, EPIX, CBIO, VRDN, NUVB, BCYC, FGEN, NVAX, KDMN, SAGE, DTIL, CMRX, CASI,
• Added Positions: KURA, BIIB, COGT, STSA, ASND, VTGN, XENE, FATE, VRNA, OTIC,
• Reduced Positions: CNST, RCKT, FOLD, APLS, MRSN, SNDX, BCRX, TGTX, IMVT, ISEE, ACRS,
• Sold Out: TVTX, SURF, FPRX, SRPT, KALV, AMRN, MLND, WVE,

For the details of Ghost Tree Capital, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/ghost+tree+capital%2C+llc/current-portfolio/portfolio

1. PowerShares QQQ Trust Ser 1 (QQQ) - 150,000 shares, 11.25% of the total portfolio.
2. Syndax Pharmaceuticals Inc (SNDX) - 1,175,000 shares, 6.17% of the total portfolio. Shares reduced by 12.96%
3. Trillium Therapeutics Inc (TRIL) - 1,950,000 shares, 4.92% of the total portfolio.
4. ARK Genomic Revolution ETF (ARKG) - 200,000 shares, 4.17% of the total portfolio.
5. Ascendis Pharma A/S (ASND) - 135,000 shares, 4.09% of the total portfolio. Shares added by 28.57%

Ghost Tree Capital, LLC initiated holding in iShares Russell 2000 ETF. The purchase prices were between $193.14 and $233.98, with an estimated average price of $217.96. The stock is now traded at around $221.020000. The impact to a portfolio due to this purchase was 1.56%. The holding were 30,000 shares as of 2021-03-31.

Ghost Tree Capital, LLC initiated holding in Celldex Therapeutics Inc. The purchase prices were between $16.19 and $29.91, with an estimated average price of $22.98. The stock is now traded at around $27.090000. The impact to a portfolio due to this purchase was 1.21%. The holding were 250,000 shares as of 2021-03-31.

Ghost Tree Capital, LLC initiated holding in ESSA Pharma Inc. The purchase prices were between $11.61 and $32.08, with an estimated average price of $23.33. The stock is now traded at around $29.360000. The impact to a portfolio due to this purchase was 1.19%. The holding were 175,000 shares as of 2021-03-31.

Ghost Tree Capital, LLC initiated holding in Catalyst Biosciences Inc. The purchase prices were between $4.93 and $7.15, with an estimated average price of $6.1. The stock is now traded at around $4.180000. The impact to a portfolio due to this purchase was 1.18%. The holding were 1,000,000 shares as of 2021-03-31.

Ghost Tree Capital, LLC initiated holding in Viridian Therapeutics Inc. The purchase prices were between $15.5 and $24.93, with an estimated average price of $18.73. The stock is now traded at around $17.420000. The impact to a portfolio due to this purchase was 1.18%. The holding were 300,000 shares as of 2021-03-31.

Ghost Tree Capital, LLC initiated holding in Nuvation Bio Inc. The purchase prices were between $9 and $14.57, with an estimated average price of $11.15. The stock is now traded at around $11.020000. The impact to a portfolio due to this purchase was 1.17%. The holding were 500,000 shares as of 2021-03-31.

Ghost Tree Capital, LLC added to a holding in Kura Oncology Inc by 84.62%. The purchase prices were between $24.76 and $39.14, with an estimated average price of $31.68. The stock is now traded at around $25.110000. The impact to a portfolio due to this purchase was 1.83%. The holding were 600,000 shares as of 2021-03-31.

Ghost Tree Capital, LLC added to a holding in Biogen Inc by 809.09%. The purchase prices were between $242.95 and $284.63, with an estimated average price of $269.82. The stock is now traded at around $280.210000. The impact to a portfolio due to this purchase was 1.17%. The holding were 20,000 shares as of 2021-03-31.

Ghost Tree Capital, LLC added to a holding in Cogent Biosciences Inc by 45.45%. The purchase prices were between $7.47 and $12.34, with an estimated average price of $9.63. The stock is now traded at around $8.020000. The impact to a portfolio due to this purchase was 1.03%. The holding were 1,600,000 shares as of 2021-03-31.

Ghost Tree Capital, LLC added to a holding in Satsuma Pharmaceuticals Inc by 352.11%. The purchase prices were between $4.57 and $7.18, with an estimated average price of $6.07. The stock is now traded at around $4.850000. The impact to a portfolio due to this purchase was 0.94%. The holding were 904,225 shares as of 2021-03-31.

Ghost Tree Capital, LLC added to a holding in Ascendis Pharma A/S by 28.57%. The purchase prices were between $124.92 and $173.33, with an estimated average price of $152.12. The stock is now traded at around $132.180000. The impact to a portfolio due to this purchase was 0.91%. The holding were 135,000 shares as of 2021-03-31.

Ghost Tree Capital, LLC added to a holding in VistaGen Therapeutics Inc by 69.82%. The purchase prices were between $1.89 and $2.96, with an estimated average price of $2.22. The stock is now traded at around $2.140000. The impact to a portfolio due to this purchase was 0.85%. The holding were 4,143,702 shares as of 2021-03-31.

Ghost Tree Capital, LLC sold out a holding in Travere Therapeutics Inc. The sale prices were between $23.37 and $31.77, with an estimated average price of $27.61.

Ghost Tree Capital, LLC sold out a holding in Surface Oncology Inc. The sale prices were between $7.25 and $13.82, with an estimated average price of $10.02.

Ghost Tree Capital, LLC sold out a holding in Five Prime Therapeutics Inc. The sale prices were between $13.81 and $38, with an estimated average price of $24.85.

Ghost Tree Capital, LLC sold out a holding in Sarepta Therapeutics Inc. The sale prices were between $72.25 and $168.95, with an estimated average price of $92.26.

Ghost Tree Capital, LLC sold out a holding in KalVista Pharmaceuticals Inc. The sale prices were between $14.69 and $42.57, with an estimated average price of $26.54.

Ghost Tree Capital, LLC sold out a holding in Millendo Therapeutics Inc. The sale prices were between $1.2 and $2.73, with an estimated average price of $2.08.